{"id":244083,"date":"2026-09-11T13:31:21","date_gmt":"2026-09-11T08:01:21","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=244083"},"modified":"2026-09-11T13:31:21","modified_gmt":"2026-09-11T08:01:21","slug":"export-pharma-stock-rises-359-percent-in-1-year","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/export-pharma-stock-rises-359-percent-in-1-year\/","title":{"rendered":"This Export Pharma Stock Rises 359% in 1 Year: Takeover Deal and Africa Growth Drive the Rally"},"content":{"rendered":"

Bliss GVS CMP approx Rs 706.70 (11 Sep 2026). 1Y return 358.71% (10 Sep close). 52W range Rs 118 to Rs 725.90. Mcap Rs 7,482 Cr. FY26 PAT Rs 134.73 Cr.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bliss GVS Pharma, an Africa-focused maker of antimalarial and anti-infective medicines, has gained approximately 359% in one year to around Rs 700. The rally came from Anupam Rasayan’s deal to buy a 43.30% stake at Rs 299 per share, a 49% jump in FY26 profit and a 26.75% EBITDA margin in the June 2026 quarter. At a PE near 53, this export pharma stock now prices in strong growth.<\/p>\n<\/div>\n

This export pharma stock has turned Rs 1 lakh into roughly Rs 4.6 lakh in a single year. A drugmaker that sells most of its medicines in Africa returned 358.71% over the past 12 months, placing it among the top 31 performers on a screen of 195 NSE small-cap stocks dated 11 September 2026.<\/p>\n

The company is Bliss GVS Pharma Ltd<\/a> (NSE: BLISSGVS), a Mumbai-based maker of antimalarial, anti-infective and women’s health medicines, best known in the market for its suppositories and pessaries. The Bliss GVS share price traded near Rs 706.70 around midday on 11 September 2026, up about 0.9% from the previous close of Rs 700.45, giving the company a market value of approximately Rs 7,482 crore.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n